[Prophylactic value of platelet anti-aggregants in coronary disease].
D000925:Anticoagulants / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000517:prevention & control; D001241:Aspirin / Q000627:therapeutic use*; D002994:Clofibrate / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D004176:Dipyridamole / Q000627:therapeutic use*; D004617:Embolism / Q000209:etiology / Q000517:prevention & control; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010974:Platelet Aggregation / Q000187:drug effects*; D011183:Postoperative Complications; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D000925:Anticoagulants; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone
Valore profilattico degli antiaggreganti piastrinici nelle coronaropatie.